Raymond Aerospace Unit Secures Multi-Programme Contracts Worth ₹33 Crore Annually
Raymond's aerospace subsidiary has been awarded contracts for over 300+ precision-machined, casting, and structural part numbers. Spanning over 37,000+ components annually, production commences across 2026 and 2027. This major domestic win supplements the company's massive ₹5,960-plus crore multi-year order backlog and aligns with its strategic transition into advanced manufacturing.
Market snapshot: Raymond Limited's aerospace subsidiary has secured multiple critical aircraft programme contracts from a prominent Indian aerospace and defence major. Under expected production limits, the contract carries an annual business potential of approximately ₹33 crore, expanding Raymond's foothold in the domestic defense manufacturing ecosystem.
Data Snapshot
- The new contract holds an annual commercial potential of approximately ₹33 crore.
- The contract covers more than 300+ precision-machined, casting, and structural part numbers.
- Annual volumes under the contract are projected to exceed 37,000+ components, with progressive production beginning through 2026 and 2027.
- Raymond's total aerospace order backlog stands at more than ₹5,960 crore over a 10-year horizon, coupled with an active RFQ pipeline of ₹1,632 crore.
What's Changed
- Secured its first major high-volume multi-programme domestic contract, shifting focus from a purely export-dominated aerospace model.
- The contract deepens Raymond's aerospace participation into structural and casting assemblies, raising its value capture rate per aircraft program.
- Raymond's Aerospace & Defence business demonstrated strong financial growth leading up to this win, with Q1 FY27 revenues jumping 40% year-on-year to ₹123 crore.
Key Takeaways
- Raymond's aerospace division has won multi-programme contracts worth approximately ₹33 crore annually.
- The order covers 300+ distinct part numbers and annual component requirements exceeding 37,000+ units.
- Production is planned to commence progressively across 2026 and 2027, stabilizing medium-term revenue visibility.
- The win secures strategic validation for Raymond's engineering capabilities across complex machining, castings, and assemblies.
SAHI Perspective
Raymond's transformation into a pure-play engineering and advanced manufacturing platform is gaining robust commercial momentum. By securing domestic multi-programme contracts that span high-precision castings and structural assemblies, Raymond is improving its product mix and operating margins. Backed by its massive ₹5,960-plus crore order book and disciplined leadership changes, the company is successfully validating its re-rating potential away from legacy consumer businesses.
Market Implications
With Raymond's stock surging up to 19.97% to reach a record high of ₹1,024 on September 11, 2026, the market is pricing in the long-term revenue visibility of its high-margin engineering businesses. Independent structural demergers of its lifestyle and real estate units have unlocked substantial capital flexibility, allowing its aerospace and automotive components arms to scale rapidly.
Trading Signals
Market Bias: Bullish
The addition of a ₹33 crore annual contract expands Raymond's already massive ₹5,960-plus crore order backlog. Strong revenue execution in the aerospace segment, which grew 40% YoY in Q1 FY27, along with an active RFQ pipeline of ₹1,632 crore, maintains a robust positive bias.
Overweight: Aerospace & Defence, Precision Engineering
Trigger Factors:
- Commencement of progressive contract production across 2026 and 2027.
- Successful monetization of the active ₹1,632 crore RFQ pipeline.
- Execution of the ₹1,000 crore capacity investment and the greenfield Andhra Pradesh facility near Bengaluru's ecosystem.
Time Horizon: Medium-term (3-12 months)
Industry Context
The Indian aerospace and defence ecosystem is witnessing an unprecedented domestic manufacturing and localization wave. Raymond's capability to supply over 1,300 aero-engine parts globally, including over 350 components for the current-generation LEAP engine platform, places it in a prime position to benefit as global aerospace tier-1 supply chains realign around specialized Indian manufacturers.
Key Risks to Watch
- Execution and strict qualification hurdles within complex aviation platforms.
- Inorganic scaling and corporate restructuring integration risks.
- Potential equity dilution over the next 18 months following the conversion of the recently approved 33.29 lakh warrants to Minerva Ventures Fund.
Recent Developments
In July 2026, Raymond appointed former Bharat Electronics (BEL) Chairman and MD Bhanu Prakash Srivastava as CEO of its defence segment to boost technological integration. Separately, in September 2026, the board approved raising ₹214.71 crore through the issuance of 33.29 lakh convertible warrants to Minerva Ventures Fund to fuel capacity expansion.
Closing Insight
With a net-debt-free status, a net cash surplus of ₹129 crore as of June 30, 2026, and a robust structural moat in advanced manufacturing, Raymond is fast establishing itself as a high-conviction defense and engineering platform.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
JPMorgan Downgrades Apollo Tyres: Navigating Commodity Headwinds and Sector Re-rating
JPMorgan Bullish on TVS Motor: Target Price Hiked to ₹4,440 as Resilience Outshines Sector Risks
JPMorgan Shifts Stance on Escorts Kubota: Upgrade to Neutral Amid Sector Recalibration
Geopolitical Friction in Hormuz: Oil Majors Flag Costs of Proposed Tolls and India’s Readiness Gaps
Recent
Siemens Proceeds With Plan to Merge Siemens Rail Automation
WeWork India Seeks NCLT Approval For ₹2,050 Crore Securities Premium Reduction
GPT Infra Unit Secures ₹85.53 Crore Order for Railway Signalling
Krystal Integrated Secures ₹6.58 Crore Monorail Facility Management Contract
Strides Pharma Receives Three Remarks From USFDA After Inspecting Alathur Facility
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.